IH (iHuman) Marketable Securities: $107.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IH iHuman Inc IH
50 GF Score
Price $1.37
GF Value $2.92
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is iHuman Marketable Securities?

iHuman IH +0.74% 50 Marketable Securities is $107.9 Mil as of Mar. 2026. GuruFocus rates IH with a GF Score™ of 50/100 and a GF Value™ of $2.92 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. iHuman's Marketable Securities for the quarter that ended in Mar. 2026 was $107.9 Mil.

iHuman's annual Marketable Securities increased from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($6.2 Mil) but then declined from Dec. 2024 ($6.2 Mil) to Dec. 2025 ($0.0 Mil).

iHuman  (NYSE:IH) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

iHuman Marketable Securities Related Terms

iHuman Marketable Securities Historical Data

* Premium members only.

The historical data trend for iHuman's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iHuman Marketable Securities Chart

iHuman Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 6.24 0.00

iHuman Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 68.94 85.89 0.00 107.87
IH
50GF Score
iHuman Inc IH
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iHuman Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $107.9 Mil mean?
iHuman (IH) has a Marketable Securities of $107.9 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on iHuman and its competitors.
Is iHuman's Marketable Securities too high?
iHuman's current Marketable Securities is $107.9 Mil. Overall, iHuman has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iHuman's Marketable Securities compare to STG and SKIL?
iHuman's Marketable Securities of $107.9 Mil can be compared against companies in the Education industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for an Education company?
A good Marketable Securities depends on the Education industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on iHuman and its competitors. iHuman's current Marketable Securities is $107.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iHuman stock overvalued right now?
Based on GuruFocus' analysis, iHuman (IH) is currently considered Significantly Undervalued. The stock's GF Value™ is $2.92, compared to a current price of $1.37 — trading 53.1% below its estimated fair value. The current Marketable Securities is $107.9 Mil. iHuman's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For iHuman (IH), the current Marketable Securities is $107.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iHuman (IH) Overvalued in 2026?

Based on GuruFocus' analysis, iHuman stock appears to be undervalued. The current stock price of $1.37 is trading 53.1% below its estimated GF Value™ of $2.92. GuruFocus considers iHuman to be Significantly Undervalued.

Key valuation signals for IH:

  • Marketable Securities: $107.9 Mil
  • GF Value™: $2.92 vs. price of $1.37 (53.1% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the IH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iHuman Business Description

Address No. 86 Beiyuan Road, Chaoyang District, Chaoyang District, Beijing, CHN, 100102
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.
50GF Score

Get the complete analysis for IH

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.37
Price
$2.92
GF Value